focus -WSS

focus

author：fashion 2025-10-01 11:46:51 - browse：451

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

The benefits and risks of Eli Lilly’s treatment for Alzheimer’s disease were confirmed in detailed scientific disclosures Monday, paving the way for its full approval but leaving physicians with lingering questions about the medicine’s impact on patients as a new era in Alzheimer’s therapy unfolds.

The drug, called donanemab, showed a 35% slowing of Alzheimer’s disease progression relative to placebo in a clinical trial that enrolled 1,700 patients with early-stage disease. Numerically, that’s a modest, 3.3-point improvement on a 144-point survey, called the Integrated Alzheimer’s Disease Rating Scale, or iADRS, that combines measures of cognition and function, such as driving, managing finances, or carrying on conversations.

There was a similar benefit when donanemab’s efficacy was assessed using a more common measure of cognition called the Clinical Dementia Rating-Sum of Boxes, or CDR-SB. On that scale, the Lilly drug showed a 36% slowing of cognitive decline relative to placebo, or 0.68 points on an 18-point scale.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： An interview with Robert F. Kennedy Jr. on vaccines

focus

WSS

Vaccine critic Robert F. Kennedy Jr. says he'll chair Trump vaccine panel

'Ancient DNA,' 23andMe reveal African American ancestries

Dramatically reducing cancer deaths requires the PASTEUR Act

Hilary expected to bring catastrophic, life

The boys, now 6, who are gene therapy’s ‘edge case’ problem

New definition of a human embryo proposed amid rapid advances

focus

focus

focus

Apple is now the first public company to be valued at $3 trillion

Patient advocates sound warning on FDA proposal on salt intake

ChatGPT in medicine: STAT answers readers' burning questions

Evacuations in place as 3 wildfires burn in eastern Washington state

How to save PrEP access — and even expand it

Evacuations in place as 3 wildfires burn in eastern Washington state

Walensky prepares to leave CDC — and Congress — behind

Eye stem cell transplant could help restore vision in injured people

Medical leaders decry Supreme Court decision on affirmative action

Ukraine taking heavy casualties 10 weeks into its counteroffensive

focus

Trump's false claims about Georgia's 2020 election long debunked

Beware the threat of staffing cuts at the CDC

Congress must give Medicare recipients genetic counseling access

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

Humana, CVS hope to turn members into patients at clinics

2 US Navy sailors arrested for allegedly spying for China

hotspot

entertainment

focus

knowledge